Between 1980 and 2014, the abortion rate declined by more than half, from 29.3 to 14.6/1000 women, according to a major new consensus study report from the National Academies of Science, Engineering, and Medicine. While the advisory committee said the reason for three-decade decline was not fully understood, it called out the increasing use of contraceptives, especially long-acting methods and historic declines in the rate of unintended pregnancy, which readers may assume go hand-in-hand with more widespread use of contraception and of highly effective contraceptive methods. Additionally, rates have been impacted by more limited access to abortion services.
Most cancers can be cured by surgery in their early stages, when the tumors are localized. What makes ovarian cancer so deadly is that distinct symptoms seldom develop until the cancer spreads outside the ovaries. The major goal for screening, therefore, is to detect ovarian cancer before it metastasizes. Researchers have developed a new “liquid biopsy” test that they hope has the capacity to identify the presence of relatively early cancers. In an early assessment, this test detected 98% of ovarian cancers in a test group of patients who had stage II or greater disease that had not yet metastasized.
What does the new study showing a link between low-dose hormonal contraceptives and breast cancer really tell us in practical terms? First, that the risk has not gone away with the introduction of pills delivering newer and lower formulations, and second, that the risk is significant at the population level but tiny at the individual level. It is important to unpack the study’s findings to really put them into perspective.
The “Contraceptive Technology” conferences will help you synthesize the data and translate the evidence into clinical “pearls” you can put directly into practice. With an array of Preconferences delving into selected specialty areas of interest, plenary sessions focusing on the “hottest” topics, a thought-provoking luncheon presentation, and 30 dynamic, interactive Concurrent Sessions, including hands-on workshops…this conference is certain to improve your clinical practice and expand your network of colleagues. Read more